1. Defects of primary hemostasis (platelet defects) cause bleeding immediately after trauma in superficial sites, while defects of secondary hemostasis (plasma protein defects) cause delayed bleeding in deep sites.
2. Physical findings in primary hemostasis defects include petechiae and ecchymoses, while secondary hemostasis defects cause hematomas and hemarthroses.
3. Defects of primary hemostasis usually have an autosomal dominant family history, while defects of secondary hemostasis often have an autosomal or X-linked recessive family history.
1. Defects of primary hemostasis (platelet defects) cause bleeding immediately after trauma in superficial sites, while defects of secondary hemostasis (plasma protein defects) cause delayed bleeding in deep sites.
2. Physical findings in primary hemostasis defects include petechiae and ecchymoses, while secondary hemostasis defects cause hematomas and hemarthroses.
3. Defects of primary hemostasis usually have an autosomal dominant family history, while defects of secondary hemostasis often have an autosomal or X-linked recessive family history.
1. Defects of primary hemostasis (platelet defects) cause bleeding immediately after trauma in superficial sites, while defects of secondary hemostasis (plasma protein defects) cause delayed bleeding in deep sites.
2. Physical findings in primary hemostasis defects include petechiae and ecchymoses, while secondary hemostasis defects cause hematomas and hemarthroses.
3. Defects of primary hemostasis usually have an autosomal dominant family history, while defects of secondary hemostasis often have an autosomal or X-linked recessive family history.
1. Defects of primary hemostasis (platelet defects) cause bleeding immediately after trauma in superficial sites, while defects of secondary hemostasis (plasma protein defects) cause delayed bleeding in deep sites.
2. Physical findings in primary hemostasis defects include petechiae and ecchymoses, while secondary hemostasis defects cause hematomas and hemarthroses.
3. Defects of primary hemostasis usually have an autosomal dominant family history, while defects of secondary hemostasis often have an autosomal or X-linked recessive family history.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 7
Differences in the Clinical Manifestations of Disorders of Primary and Secondary Hemostasis
Manifestations Defects of Primary Hemostasis
(Platelet Defects) Defects of Secondary Hemostasis (Plasma Protein Defects) Onset of bleeding after trauma Immediate Delayed (hours or days) Sites of bleeding Superficial skin, mucous membranes, nose, gastrointestinal and genitourinary tracts Deep (joints, muscle, retroperitoneum) Physical findings Petechiae, ecchymoses Hematomas, hemarthroses Family history Autosomal dominant Autosomal or X-linked recessive Response to therapy Immediate; local measures effective Requires sustained systemic therapy
EXPLORAREA HEMOSTAZEI PRIMARE TESTELE DE SCREENING : Timpul de sangerare - TS Numararea placutelor sanguine
Primary Hemostatic (Platelet) Disorders 1. Defects of platelet adhesion - von Willebrand's disease - Bernard-Soulier syndrome (absence or dysfunction of GpIb/IX) 2. Defects of platelet aggregation - Glanzmann's thrombasthenia (absence or dysfunction of GpIIb/IIIa) 3. Defects of platelet release Decreased cyclooxygenase activity - Drug-induced (aspirin, nonsteroidal anti-inflammatory agents) - Congenital Granule storage pool defects - Congenital - Acquired Uremia Platelet coating (e.g., penicillin or paraproteins) 4. Defect of platelet coagulant activity - Scott's syndrome
Evaluation of Platelet Function Bleeding time Modified Ivy method Skin incision (time to stop bleeding) Global screen of platelet role in hemostasis von Willebrand factor assays vWF Ag (immunoassay of total vWF protein) vWF R:Cof (bioassay of vWF that measures ability of patient plasma to support agglutination of normal platelets in the presence of ristocetin) Factor VIII (coagulation assay of factor VIII bound and carried by plasma vWF) Platelet aggregometry Measures platelet aggregation in response to a panel of agonists, usually ADP, collagen, arachidonic acid, and epinephrine Membrane glycoproteins Presence of glycoproteins Ib-IX and IIb-IIIa can be measured using monoclonal antibodies and flow cytometry Platelet granule content Dense granules (electron microscopy or uptake and retention of radiolabeled serotonin) Alpha granules (electron microscopy and/or immunoassays for platelet-associated proteins - vWF, fibrinogen, platelet factor four
EXPLORAREA HEMOSTAZEI SECUNDARE (COAGULAREA) TESTE DE SCREENING : TCG TC (aPTT) TIMPUL DE PROTROMBINA (QUICK) = PT TIMPUL DE TROMBINA FIBRINOGENEMIA
Relationship between Secondary Hemostatic Disorders and Coagulation Test Abnormalities Prolonged partial thromboplastin time (PTT) No clinical bleeding (factors XII, HMWK, PK) Mild or rare bleeding (factor XI) Frequent, severe bleeding (factors VIII and IX) Prolonged prothrombin time (PT) Factor VII deficiency Vitamin K deficiency - early Warfarin anticoagulant ingestion Prolonged PTT and PT Factor II, V, or X deficiency Vitamin K deficiency - late Warfarin anticoagulant ingestion Prolonged thrombin time (TT) Mild or rare bleeding, afibrinogenemia Frequent, severe bleeding, dysfibrinogenemia Heparin-like inhibitors or heparin administration Prolonged PT and/or PTT not corrected with normal plasma Specific or nonspecific inhibitor syndromes Clot solubility in 5 M urea Factor XIII deficiency Inhibitors or defective cross-linking Rapid clot lysis a2 plasmin inhibitor
Dg. diferential : deficit de FPC / deficit de VK TESTUL KOLLER DEFICIT FPC DEFICIT DE VK APTT / PT APTT / PT
Administrare de VK (i.m.) 8 12 ore APTT / PT (nu se corecteaza) APTT / PT = N (se corecteaza) TEST KOLLER (-) TEST KOLLER (+)
APTT = N APTT PT = N PT TT = N TT Fibrinogenemie (disproportionat) Fibrinogenemie Tr-citopenie Tr-citopenie TLCS, TLCE TLCS, TLCE PDF +++ PDF +++ D-Dimer = N D-Dimer